Article
Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals.
Molecular psychiatry - 1 Nov 2009
Baehne C G, Ehlis A-C, Plichta M M, Conzelmann A, Pauli P, Jacob C, Gutknecht L, Lesch K-P, Fallgatter A J
Abstract excerpt
Although therapeutic interventions in attention-deficit/hyperactivity disorder (ADHD) still focus on the dopaminergic system, recent studies indicate a serotonergic dysfunction in this disease as well. In that respect, several variants of the tryptophan hydroxylase gene (TPH2), which codes for the rate-limiting enzyme in the biosynthesis of serotonin (5-HT), have been associated with ADHD. The rs4570625 G-allele...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
